Literature DB >> 23014845

Early diagnosis of hepatocellular carcinoma by microRNAs: shining a light from the genome's "dark matter".

Alejandro H Corvalan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23014845     DOI： 10.1007/s10620-012-2384-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  24 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

Review 2.  Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.

Authors:  Zdenko Herceg; Anupam Paliwal
Journal:  Mutat Res       Date:  2011-04-15       Impact factor: 2.433

3.  Shining a light on the genome's 'dark matter'.

Authors:  Elizabeth Pennisi
Journal:  Science       Date:  2010-12-17       Impact factor: 47.728

4.  Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.

Authors:  Li-Min Li; Zhi-Bin Hu; Zhen-Xian Zhou; Xi Chen; Fen-Yong Liu; Jun-Feng Zhang; Hong-Bing Shen; Chen-Yu Zhang; Ke Zen
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

Review 5.  Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

Authors:  Donald Poon; Benjamin O Anderson; Li-Tzong Chen; Koichi Tanaka; Wan Yee Lau; Eric Van Cutsem; Harjit Singh; Wan Cheng Chow; London Lucien Ooi; Pierce Chow; Maung Win Khin; Wen Hsin Koo
Journal:  Lancet Oncol       Date:  2009-11       Impact factor: 41.316

Review 6.  Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.

Authors:  W Alazawi; M Cunningham; J Dearden; G R Foster
Journal:  Aliment Pharmacol Ther       Date:  2010-05-22       Impact factor: 8.171

Review 7.  The role of microRNAs in the management of liver cancer.

Authors:  Krishna K Banaudha; Mukesh Verma
Journal:  Methods Mol Biol       Date:  2012

8.  Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.

Authors:  Yang Li; Weiqi Tan; Thomas W L Neo; Myat O Aung; Shanthi Wasser; Seng G Lim; Theresa M C Tan
Journal:  Cancer Sci       Date:  2009-04-15       Impact factor: 6.716

Review 9.  New cancer biomarkers deriving from NCI early detection research.

Authors:  Mukesh Verma; Sudhir Srivastava
Journal:  Recent Results Cancer Res       Date:  2003

10.  Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.

Authors:  Silvia Cermelli; Anna Ruggieri; Jorge A Marrero; George N Ioannou; Laura Beretta
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240
View more
  6 in total

1.  AU-binding factor 1 expression was correlated with metadherin expression and progression of hepatocellular carcinoma.

Authors:  Yingzhuo Yang; Peng Kang; Jie Gao; Chunlin Xu; Shimei Wang; Haiyu Jin; Yunling Li; Wenjuan Liu; Xia Wu
Journal:  Tumour Biol       Date:  2013-11-09

Review 2.  Radiotherapeutic options for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Dong Soo Lee; Jinsil Seong
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

3.  Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.

Authors:  Qibin Liao; Peiyu Han; Yue Huang; Zhitong Wu; Qing Chen; Shanshan Li; Jufeng Ye; Xianbo Wu
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 4.  Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis.

Authors:  Qing-Qin Hao; Guang-Yi Chen; Jun-Hua Zhang; Jia-He Sheng; Yun Gao
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 5.  MicroRNA-21 as a diagnostic marker for hepatocellular carcinoma: A systematic review and meta-analysis.

Authors:  Juan Qu; Jizhi Yang; Ming Chen; Lihong Cui; Tianxi Wang; Wei Gao; Jingjing Tian; Rongna Wei
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

6.  ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC).

Authors:  Shujuan Pan; Xiaoyun Cheng; Hongan Chen; Patricia D Castro; Michael M Ittmann; Anne W Hutson; Susan K Zapata; Richard N Sifers
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.